Company Stellar Biotechnologies Inc Nasdaq
Equities
CA85855A3029
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Pardeep Nijhawan
FOU | Founder | 53 | 11/06/07 |
Michael Brooks
PSD | President | 46 | 31/08/15 |
Stephen Lemieux
DFI | Director of Finance/CFO | 48 | 14/07/23 |
Blair Gordon
CTO | Chief Tech/Sci/R&D Officer | - | 31/08/16 |
Gary Koppenjan
IRC | Investor Relations Contact | - | 31/12/18 |
Raj Puri
PRN | Corporate Officer/Principal | - | 22/06/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Sean MacDonald
BRD | Director/Board Member | 47 | 06/06/19 |
Frank Oakes
BRD | Director/Board Member | 73 | 08/04/10 |
Patrick Marshall
BRD | Director/Board Member | 53 | 22/05/23 |
Joan Chypyha
BRD | Director/Board Member | 57 | 22/05/23 |
Charles Olson
BRD | Director/Board Member | 66 | 22/05/23 |
Pardeep Nijhawan
FOU | Founder | 53 | 11/06/07 |
Carlo Sistilli
CHM | Chairman | 67 | 06/06/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,215,968 | 2,120,255 ( 65.93 %) | 0 | 65.93 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+18.15% | 124B | |
+18.02% | 112B | |
+4.63% | 22.94B | |
-9.86% | 17.02B | |
-16.47% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B | |
+106.26% | 10.31B |